NASDAQ:OCUL

Ocular Therapeutix Stock Predictions

Healthcare > Biotechnology

Buy OCUL

*Your capital is at risk

$8.35

+0.0400 (+0.481%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

OCUL Prediction Chart

OCUL Predictions History

Latest community submissions for OCUL.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
JS Pro	Feb 8, 2018	$5.25 +4.37%	$5.05	V	96.00%	0
JS Pro	Jun 2, 2017	$10.79 -1.91%	$11.00	X	98.10%	0
JS Pro	May 4, 2017	$9.14 +0.44%	$9.10	X	99.60%	4
Uzi.Babadzhanov.1794	Dec 9, 2016	$9.34 +0.54%	$9.29	X	99.50%	3
Stockdum Senior	Aug 8, 2016	$6.44 +5.40%	$6.11	X	94.60%	0
StockInvest Amateur	Aug 8, 2016	$6.30 +3.11%	$6.11	X	96.90%	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for OCUL with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT OCULAR THERAPEUTIX

Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cataract surgery; and DEXTENZA, a dexamethasone ophthalmic insert to treat post-surgical ocular inflammati...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by